INVX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Innovex International Inc (INVX) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The technical indicators are neutral, options data suggests mixed sentiment, and the financial performance shows declining profitability despite revenue growth. Additionally, insider selling is a significant negative catalyst. While analysts have slightly raised the price target, the lack of strong positive catalysts and the absence of proprietary trading signals make this stock a 'hold' for now.
The MACD histogram is negative and contracting (-0.124), RSI is neutral at 49.678, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 24.55, with resistance at 25.268 and support at 23.832.
Barclays raised the price target from $20 to $24, citing a strong Q4 report. Revenue grew by 9.14% YoY in 2025/Q4.
No recent news or congress trading data to provide additional support.
In 2025/Q4, revenue increased to $273.6M (up 9.14% YoY), but net income dropped to $13.97M (-56.06% YoY), EPS fell to 0.2 (-39.39% YoY), and gross margin declined to 23.26% (-19.93% YoY).
Barclays raised the price target from $20 to $24 and maintained an Equal Weight rating, reflecting a cautious but slightly optimistic outlook.
